Evidence map›Paper›PMID 38151523›Full record

ArticleScientific reports2023

Plant-expressed Zika virus envelope protein elicited protective immunity against the Zika virus in immunocompetent mice.

Minna Shin, Hyangju Kang, Kyeong Ryeol Shin, Rangyeon Lee, Kiju Kim, Kyungmin Min, Kyou-Nam Cho, Eun-Ju Sohn, Kwang Sung Kim, Seok-Hyun Kim and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Minna Shin *INNOVAC, Chuncheon, 24341, Republic of Korea.
Hyangju Kang *BioApplications Inc., Pohang Techno Park Complex, 394 Jigok-Ro Nam-Gu, Pohang, Korea. hyangju@bioapp.co.kr.
Kyeong Ryeol ShinINNOVAC, Chuncheon, 24341, Republic of Korea.
Rangyeon LeeCollege of Veterinary Medicine & Institute of Veterinary Science, Kangwon National University, Chuncheon, 24341, Republic of Korea.
Kiju KimINNOVAC, Chuncheon, 24341, Republic of Korea.
Kyungmin MinBioApplications Inc., Pohang Techno Park Complex, 394 Jigok-Ro Nam-Gu, Pohang, Korea.
Kyou-Nam ChoBioApplications Inc., Pohang Techno Park Complex, 394 Jigok-Ro Nam-Gu, Pohang, Korea.
Eun-Ju SohnBioApplications Inc., Pohang Techno Park Complex, 394 Jigok-Ro Nam-Gu, Pohang, Korea.
Kwang Sung KimEYEGENE Inc., B-1211, 401 Yangcheon-Ro, Gangseo-Gu, Seoul, 07528, Republic of Korea.
Seok-Hyun KimEYEGENE Inc., B-1211, 401 Yangcheon-Ro, Gangseo-Gu, Seoul, 07528, Republic of Korea.
Yang Je ChoEYEGENE Inc., B-1211, 401 Yangcheon-Ro, Gangseo-Gu, Seoul, 07528, Republic of Korea.
Jeongho ParkCollege of Veterinary Medicine & Institute of Veterinary Science, Kangwon National University, Chuncheon, 24341, Republic of Korea. jhp@kangwon.ac.kr.
Tae-Wook HahnINNOVAC, Chuncheon, 24341, Republic of Korea. twhahn@kangwon.ac.kr.
Pohang TechnoPark (South Korea) · KRKangwon National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zika virus infection causes multiple clinical issues, including Guillain-Barré syndrome and neonatal malformation. Vaccination is considered as the only strategy for the prevention of ZIKV-induced clinical issues. This study developed a plant-based recombinant vaccine that transiently expressed the ZIKV envelope protein (ZikaEnv:aghFc) in Nicotiana benthamiana and evaluated the protective immunity afforded by it in immunocompetent mice. ZikaEnv:aghFc induced both humoral and cellular immunity at a low dose (1-5 μg). This immune-inducing potential was enhanced further when adjuvanted CIA09A. In addition, antigen-specific antibodies and neutralizing antibodies were vertically transferred from immunized females to their progeny and afforded both protective immunity to ZIKV and cross-protection to Dengue virus infection. These results suggest that our plant-based ZIKV vaccine provides a safe and efficient protective strategy with a competitive edge.

Indexed as

Viral VaccinesZika VirusZika Virus InfectionAnimalsAntibodies, NeutralizingAntibodies, ViralFemaleMiceViral Envelope ProteinsAntibodies, NeutralizingAntibodies, ViralViral Envelope ProteinsViral Vaccines

Identifiers

PMID38151523
PMCPMC10752873
OpenAlexW4390268554

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.